– Artrite psoriásica, espondilite anquilosante e espondiloartropatia indiferenciada são as outras condições incluídas nas espondiloartropatias inflamatórias que compartilham características clínicas e etiológicas comuns.
– As manifestações extra intestinais que afetam a pele, olhos e articulações se desenvolvem em cerca de um quarto dos pacientes com doença inflamatória intestinal (DII) sendo as manifestações osteomusculares as mais comuns, com aproximadamente 5-20% dos indivíduos com DII desenvolvendo artrite periférica e/ou espondilite.
– O envolvimento axial na DII ocorre em qualquer idade, em contraste com a EA idiopática, que afeta homens com menos de 40 anos.
■ Systematic review and meta-analysis of inflammatory bowel disease adverse events with anti-interleukin 17A agents and tumor necrosis factor inhibitor in rheumatic disease and skin psoriasis
Steven L. Truong, Jasmine Chin, David F. L. Liew et al
Rheumatol Ther.2021, vol 8(4): 1603–1616
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8572260/
■ Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review
J Evans, M Sa0sford, S McDonald et al
Their Adv Musculoskelet Dis 2021, vol 13: 1759720X21996973
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7958176/
■ Managing Psoriatic arthritis with inflammatory bowel disease and/or uveitis
A Y T Chia, G W X Ang, A S Y Chan et al
Front Med September 2021
https://www.frontiersin.org/articles/10.3389/fmed.2021.737256/full
■ Inhibition of phosphodiesterease-4 in psoriatic arthritis and inflammatory bowel disease
Andrea Picchianti-Diamanti, Francesca Romana Spinelli, Maria Manuela Rosado et al
Int J Mol Sci.2021, vol 22(5): 2638
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7961737/
■ IBD consideration in spondyloarthritis
C D Jiang, T Raine
Ther Adv Musculoskelet Dis 2020:vol 12: 1759720X20939410
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7350041/
■ Chronic pain in patients with inflammatory bowel disease
Nikul Bakshi, Ailsa L. Hart, Michael C. Lee et al
Pain.2021, vol 162(10): 2466–2471
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8442739/
■ The arthritis conncetion to inflammatory bowel disease (IBD): why has it taken so long to undertand it?
Maedeh Ashrafi, Kristine A Kuhn, Michael H Weisman
RMD Open.2021; vol 7(1): e001558
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8055104/
■ Low incidence of inflammatory bowes disease adverse events in adalimumab clinical trials across nine different diseases
Dirk Elewaut, Jürgen Braun, Jaclyn K. Anderson et al
Arthritis Care Res (Hoboken)2021, vol 73(2): 289–29
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7898340/
■ From bowel inflammatory to the bone and joints: musculoskeketal examination in inflammatory bowel disease (IBD)
S Tavassoli, I Shahabinasab, A Norouzi et al
BMC Musculoskelet Disord 2021, vol 22: 1019
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8645134/
■ Management of patients with inflammatory bowel disease and spondyloarthritis
L Pouillonm P Bossuyt, J Vanderstukken, D Moulin et al
Expert Review of Clinical Pharmacology, Informa Plc, 2017, vol 10 (12): 1363-1374
https://hal.univ-lorraine.fr/hal-01715137/document
■ Doença Inflamatória Intestinal: Diretrizes Médicas (Inflammatory Bowel Disease: Guidelines)
Arquivo Blog Internet Médica – fevereiro 2021
■ Doença inflamatória intestinal: Organizações Médicas (Inflammatory Bowel Disease: Medical Organizations)
Arquivo Blog Internet Médica – julho 2020
■ Artrite Psosiásiva: Artigos de Revisão (Psoriatic Arthritis: Reviews)
Arquivo Blog Internet Médica – julho 2020
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: dezembro 2021